Ticker Details
Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
IPO Date:	November 10, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 3.61%
Avg Daily Range (30 D):	$1.16 | 2.79%
Avg Daily Range (90 D):	$1.34 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	1.26M
Avg Daily Volume (90 D):	1.47M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	2,336
Avg Institutional Trade:	$2.81M
Avg Institutional Trade (30 D):	$2.68M
Avg Institutional Trade (90 D):	$2.87M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.69M
Avg Closing Trade (30 D):	$7.72M
Avg Closing Trade (90 D):	$7.5M
Avg Closing Volume:	103.49K

News

Jan 16, 2026 @ 5:36 PM Soleno Therapeutics (SLNO) Faces Investor Scrutiny... Source: Hagens Berman

Jan 8, 2026 @ 10:00 PM Bragar Eagel & Squire, P.C. Encourages Soleno, Avi... Source: Bragar Eagel & Squire, P.C.

Dec 30, 2025 @ 9:50 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 11, 2025 @ 6:17 PM Rhythm Pharma Strikes Chord As Early PWS Trial Res... Source: Vandana Singh

Dec 4, 2025 @ 12:02 AM Soleno Turns First Profit on $66 Million in Revenu... Source: Jonathan Ponciano

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.81	$.49	$-.09
Diluted EPS	$-1.83	$.47	$-.09
Revenue	$98.68M	$66.02M	$32.66M
Gross Profit		$64.88M	$31.96M
Net Income / Loss	$-78.45M	$26.01M	$-4.71M
Operating Income / Loss	$-89.28M	$22.11M	$-6.53M
Cost of Revenue		$1.14M	$.7M
Net Cash Flow	$198.25M	$170.17M	$-4.83M
PE Ratio

Splits
Aug 26, 2022	1:15
Oct 06, 2017	1:5